Executives
-
Boehnlein Glenn SVP, Chief Financial Officer -
Pierce James AndrewGroup President
-
Berry William E JrVP, Chief Accounting Officer
-
Stiles Spencer SGroup President
-
Becker Yin CVP, Chief Corp Affairs Officer
-
Fink M KathrynVP, Chief HR Officer
-
Menon VijuGroup President
-
Fletcher Robert SVP, Chief Legal Officer
?
Fink M Kathryn
VP, Chief HR Officer
Stryker Corporation
US, Kalamazoo [HQ]
CIK
1663095
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
12,163
Price per Share :
$381.79
Equivalence :
$4,643,711.77
Transaction History
-
F12,163 Shares After TransactionValue : $4,092,849.50$47,110.00Transaction Date : 05/01/24
-
Footnotes
-
-
Footnotes:#1 Includes 126 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of March 31, 2024, the date of the latest available statement of the reporting person's ESPP holdings.
-
A13,627 Shares After TransactionValue : $n/a$0.0Transaction Date : 03/11/24
-
Footnotes
-
-
Footnotes:#1 Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2024.#2 Includes 108 shares of Stryker Common Stock acquired pursuant to Stryker Corporation's Employee Stock Purchase Plan ("ESPP") as of December 31, 2023, the date of the latest available statement of the reporting person's ESPP holdings.
-
M13,710 Shares After TransactionValue : $n/a$0.0Transaction Date : 03/21/24
-
Footnotes
-
-
Footnotes:#1 On March 13, 2024, the Reporting Person filed a Form 4 reporting the acquisition of 3,463 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2024 (the "Performance Stock Units"). The 83 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2024 and were settled for an equal number of shares of Stryker Common Stock.
-
F12,285 Shares After TransactionValue : $4,338,939.15$503,295.75Transaction Date : 03/21/24
-
Footnotes
-
-
Footnotes:#1 On March 13, 2024, the Reporting Person filed a Form 4 reporting the acquisition of 3,463 shares of Stryker Common Stock earned upon the satisfaction of certain performance criteria, subject to vesting on March 21, 2024 (the "Performance Stock Units"). The 83 shares being reported here represent dividend equivalents issued in connection with the earned Performance Stock Units, which also vested on March 21, 2024 and were settled for an equal number of shares of Stryker Common Stock.
-
S10,042 Shares After TransactionValue : $3,715,540.00Sold $784,770.00Transaction Date : 09/13/24
-
Footnotes
-
-
Footnotes:#1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2024.#2 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $360.785 to $361.35, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.#3 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $361.865 to $362.72, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.#4 The price reported in Column 4 is a weighted average sale price. The shares of Common Stock were sold in multiple transactions at prices ranging from $362.84 to $363.835, inclusive. The Reporting Person undertakes to provide upon request by the staff of the Securities & Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the range set forth herein.